loadpatents
name:-0.20280480384827
name:-0.029549121856689
name:-0.0014979839324951
Rewcastle; Gordon William Patent Filings

Rewcastle; Gordon William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rewcastle; Gordon William.The latest application filed is for "tricyclic heterocyclic derivatives and uses thereof".

Company Profile
1.23.20
  • Rewcastle; Gordon William - Auckland NZ
  • Rewcastle; Gordon William - Glendowie NZ
  • Rewcastle; Gordon William - Manerewa NZ
  • Rewcastle; Gordon William - Manurewa NZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic heterocyclic derivatives and uses thereof
Grant 11,028,064 - Gamage , et al. June 8, 2
2021-06-08
Tricyclic Heterocyclic Derivatives And Uses Thereof
App 20190276423 - GAMAGE; Swarnalatha Akuratiya ;   et al.
2019-09-12
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
Grant 9,108,980 - Rewcastle , et al. August 18, 2
2015-08-18
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy
App 20150038486 - Rewcastle; Gordon William ;   et al.
2015-02-05
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
Grant 8,772,287 - Rewcastle , et al. July 8, 2
2014-07-08
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy
App 20130289016 - Rewcastle; Gordon William ;   et al.
2013-10-31
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
Grant 8,486,939 - Rewcastle , et al. July 16, 2
2013-07-16
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
Grant 8,461,158 - Rewcastle , et al. June 11, 2
2013-06-11
Substituted Pyrimidines And Triazines And Their Use In Cancer Therapy
App 20110053907 - Rewcastle; Gordon William ;   et al.
2011-03-03
Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles And Their Use In Cancer Therapy
App 20110009405 - Rewcastle; Gordon William ;   et al.
2011-01-13
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy
App 20100249099 - Rewcastle; Gordon William ;   et al.
2010-09-30
Imidazopyridine And Imidazopyrimidine Derivatives As Antibacterial Agents
App 20090275577 - Sciotti; Richard John ;   et al.
2009-11-05
Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents
Grant 7,563,788 - Sciotti , et al. July 21, 2
2009-07-21
5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives
Grant 7,273,877 - Black , et al. September 25, 2
2007-09-25
Antibacterial agents
App 20070191394 - Sciotti; Richard John ;   et al.
2007-08-16
Pteridinones As Kinase Inhibitors
App 20070049600 - Denny; William Alexander ;   et al.
2007-03-01
Pteridinones as kinase inhibitors
Grant 7,169,778 - Denny , et al. January 30, 2
2007-01-30
N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
Grant 7,078,438 - Rewcastle , et al. July 18, 2
2006-07-18
5-substituted tetralones as inhibitors of ras farnesyl transferase
Grant 6,943,183 - Denny , et al. September 13, 2
2005-09-13
N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
App 20050137263 - Rewcastle, Gordon William ;   et al.
2005-06-23
N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
Grant 6,891,066 - Rewcastle , et al. May 10, 2
2005-05-10
Imidazopyridines and triazolopyridines
App 20050049276 - Kaufman, Michael David ;   et al.
2005-03-03
5-Substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives
App 20050026964 - Black, Shannon Leigh ;   et al.
2005-02-03
Dihydro-2H-naphthalene-1-one inhibitors of ras farnesyl transferase
App 20040171844 - Leonard, Daniele Marie ;   et al.
2004-09-02
N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
Grant 6,770,778 - Barrett , et al. August 3, 2
2004-08-03
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,713,484 - Bridges , et al. March 30, 2
2004-03-30
5- substituted tetralones as inhibitors of ras farnesyl trransferase
App 20040044057 - Denny, William Alexander ;   et al.
2004-03-04
N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
App 20040006245 - Rewcastle, Gordon William ;   et al.
2004-01-08
N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
App 20030232889 - Barrett, Stephen Douglas ;   et al.
2003-12-18
Dihydro-2h-napthalene-1-one inhibitors of ras farnesyl transferase
App 20030232790 - Leonard, Daniele Marie ;   et al.
2003-12-18
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
App 20030186987 - Bridges, Alexander James ;   et al.
2003-10-02
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,596,726 - Bridges , et al. July 22, 2
2003-07-22
Pteridinones as kinase inhibitors
App 20030130286 - Denny, William Alexander ;   et al.
2003-07-10
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,521,620 - Bridges , et al. Feb
2003-02-18
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,455,534 - Bridges , et al. Sept
2002-09-24
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
App 20010027197 - Bridges, Alexander James ;   et al.
2001-10-04
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,265,410 - Bridges , et al.
2001-07-24
Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,084,095 - Bridges , et al.
2000-07-04
Treatment of cancers
Grant 5,696,131 - Baguley , et al. December 9, 1
1997-12-09
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 5,679,683 - Bridges , et al. Oc
1997-10-21
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 5,654,307 - Bridges , et al.
1997-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed